REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 14th, 2010 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 8, 2009 by and among Titan Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the signatories hereto (each a “Purchaser” and collectively, the “Purchasers”).
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • January 14th, 2010 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of December 18, 2009 between OXFORD FINANCE CORPORATION (“Lender”), and TITAN PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”), provides the terms on which Lender shall lend to Borrower and Borrower shall repay Lender. The parties agree as follows:
SUBLEASESublease Agreement • January 14th, 2010 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
THIS SUBLEASE AGREEMENT (“Sublease”) is made and entered into on March 27, 2009 by and between TITAN PHARMACEUTICAL, INC., a Delaware corporation (hereinafter “Sublessor”), and ANESIVA, INC., a Delaware corporation (hereinafter “Sublessee”).
OYSTER POINT MARINA PLAZA Eighth Amendment to Office LeaseOffice Lease • January 14th, 2010 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
THIS EIGHTH AMENDMENT TO OFFICE LEASE (the “Eighth Amendment”) is made and entered into as of April 17, 2007, by and between KASHIWA FUDOSAN AMERICA, INC., a California corporation (“LandLord”) and TITAN PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
